** Shares of Trajan Group Holdings TRJ.AX rise 11.5% to A$0.925, eyeing their best trading session since mid-May 2024
** Stock hits highest since February 6
** Life sciences co logs 1H25 adjusted EBITDA of A$7.9 mln ($4.97 mln) vs A$4 mln during the same period last year
** Attributes earnings growth to strong distribution from its capital equipment segment
** Also reaffirms net revenue guidance of A$160 mln-A$165 mln for fiscal 2025 vs A$155 mln in FY24
** More than 66,000 shares change hands, 3.6 times the 30-day avg
** Traja down 18.1% YTD, including current session's moves
($1 = 1.5908 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。